dockets: FDA-2026-P-3632

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-3632 FDA Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons. Nonrulemaking 2026-04-02T21:19:55Z 0b000064b924c546         ["CDER", "Citizen Petition", "Premier Research International LLC", "to determine that", "PRALIDOXIME CHLORIDE AUTOINJECTOR", "600 mg 2 mL intramuscular solution", "NDA 018986", "from Meridian Medical Technologies Inc", "was not discontinued or", "withdrawn due to safety or efficacy reasons", "OPEN"] CDER Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued.     {"displayProperties": [{"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["CDER", "Citizen Petition", "Premier Research International LLC", "to determine that", "PRALIDOXIME CHLORIDE AUTOINJECTOR", "600 mg 2 mL intramuscular solution", "NDA 018986", "from Meridian Medical Technologies Inc", "was not discontinued or", "withdrawn due to safety or efficacy reasons", "OPEN"], "modifyDate": "2026-04-02T21:19:55Z", "dkAbstract": null, "agencyId": "FDA", "program": "CDER", "shortTitle": "Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued.", "subType2": null, "title": "Requests that the FDA to determine that PRALIDOXIME CHLORIDE (AUTOINJECTOR) 600 mg/2 mL intramuscular solution, (NDA 018986) from Meridian Medical Technologies Inc. was not discontinued or withdrawn due to safety or efficacy reasons.", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b000064b924c546"} single_get

Links from other tables